Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Seropositivity × Drug Therapy × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 140 Lung Neoplasms 55 Small Cell Lung Carcinoma 22 Neoplasms 9 NSCLC 8 Mesothelioma, Malignant 8 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Stomach Neoplasms 3 Brain Neoplasms 3 Adenocarcinoma of Lung 3 Thymoma 2 Small Cell Lung Cancer Limited Stage 2 Sarcoma 2 Pleural Effusion, Malignant 2 NSCLC Stage IV Without EGFR/ALK Mutation 2 Mesothelioma 2 Liver Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Extensive Stage Small Cell Lung Cancer 2 Cholangiocarcinoma 2 Carcinoma 2

Interventions

Tomography, X-Ray Computed 1 Spirometry 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01296113 2023-03-14

CHIVA

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, HIV Seropositivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡